Inventor · disambiguated record
Jay P. Madan
Also filed as: MADAN JAY · MADAN JAY P
6 granted patents·7 pending applications·6 citations·filing 2018–2024
72Inventor score
Top patents by PatentIndex Score
13 records- 0184US11278587B2Treatment of cancer with larazotide derivatives in combination with immune checkpoint inhibitors9 METERS BIOPHARMA INC·Filed 2021·Granted Mar 22, 2022·2 cites·23 claims
- 0280US11058902B2Compositions and methods for treating disease associated with permeability of intestinal epithelium9 METERS BIOPHARMA INC·Filed 2018·Granted Jul 13, 2021·4 cites·24 claims
- 0366US2024325463A1Compositions and methods for treating or preventing intestinal paracellular permeabilityINTERLUDE BIOPHARMA CO·Filed 2024·Application pending·0 cites
- 0465US2023340022A1Compounds and methods for treating tight junction permeability9 METERS BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 0564US12016889B2Compositions and methods for treating or preventing intestinal paracellular permeability9 METERS BIOPHARMA INC·Filed 2019·Granted Jun 25, 2024·0 cites·13 claims
- 0663US11608359B2Compounds and methods for treating tight junction permeabtility9 METERS BIOPHARMA INC·Filed 2019·Granted Mar 21, 2023·0 cites·18 claims
- 0757US12337024B2Larazotide formulationsINTERLUDE BIOPHARMA CO·Filed 2020·Granted Jun 24, 2025·0 cites·17 claims
- 0854US2021299481A1Compositions and methods for treating disease associated with permeability of intestinal epithelium9 METERS BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 0947US12414979B2Compositions and methods for treating Sjogren's syndromeINTERLUDE BIOPHARMA CO·Filed 2021·Granted Sep 16, 2025·0 cites·10 claims
- 1047US2021169968A1Compositions and methods for potentiating immune checkpoint inhibitor therapy9 METERS BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 1146US2023218706A1Larazotide derivatives comprising d-amino acids9 METERS BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 1244US2021361734A1Compositions and methods for potentiating immune checkpoint inhibitor therapy9 METERS BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 1340US2022143046A1Composition and methods for rectal delivery of 4-aapa and 5-asa compounds9 METERS BIOPHARMA INC·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →